Activation of tumor necrosis factor-alpha and lymphotoxin-alpha via anti-CD40 in human B cells.
Worm
M
M
Division of Immunology, Children's Hospital, Boston, MA 02115, USA.
Geha
R S
RS
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D015703:Antigens, CD / Q000276:immunology / Q000502:physiology*; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology / Q000502:physiology*; D001402:B-Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D002051:Burkitt Lymphoma / Q000473:pathology; D019013:CD40 Antigens; D002462:Cell Membrane / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D008233:Lymphotoxin-alpha / Q000096:biosynthesis* / Q000235:genetics; D014066:Palatine Tonsil / Q000166:cytology; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis* / Q000235:genetics
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; D019013:CD40 Antigens; D008233:Lymphotoxin-alpha; D014409:Tumor Necrosis Factor-alpha